2007
DOI: 10.1016/j.transproceed.2007.05.061
|View full text |Cite
|
Sign up to set email alerts
|

Modifications of Intracranial Pressure After Molecular Adsorbent Recirculating System Treatment in Patients With Acute Liver Failure: Case Reports

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…In adults suffering from ALF, a significant (p Ͻ .001) decrease in HE closely related to a decreased cerebral blood flow and falling serum ammonium levels during MARS has been reported (26,27).…”
Section: Discussionmentioning
confidence: 97%
“…In adults suffering from ALF, a significant (p Ͻ .001) decrease in HE closely related to a decreased cerebral blood flow and falling serum ammonium levels during MARS has been reported (26,27).…”
Section: Discussionmentioning
confidence: 97%
“…It was demonstrated that MARS improves hepatic encephalopathy in chronic liver failure (23). Clinical data evaluating the effect of MARS on ICP are lacking, despite a promising preliminary report (24). Personally, the authors observed the development of intracranial hypertension, brain stem herniation, and brain death during MARS treatment in a young patient waiting for urgent liver transplantation (unpublished personal data).…”
Section: Discussionmentioning
confidence: 99%
“…Along with this two-stage procedure, there have been other efforts, such as the use of liver support devices, to sustain the acute or fulminant liver failure patients until a liver graft is ready [13,14]. Bioartificial liver support using charcoal columns and extracorporeal devices filled with the liver tissue has been reported [13], and more recently the MARS has been introduced as a nonbiological liver support device [14,15].…”
Section: Discussionmentioning
confidence: 99%
“…Bioartificial liver support using charcoal columns and extracorporeal devices filled with the liver tissue has been reported [13], and more recently the MARS has been introduced as a nonbiological liver support device [14,15]. The application of these devices is a relatively common clinical practice because they remove toxic materials from the patients' plasma, thus providing the patients with more time to wait for a liver graft by improving the hemodynamic profiles and alleviating the increased intracranial pressure.…”
Section: Discussionmentioning
confidence: 99%